UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 4, 2022
Accession Number:
Submission Type:
CIK: 0000910267
Company Name: TITAN PHARMACEUTICALS INC
File Number: 333-262614